Press Ganey Appoints Avanish Mishra, Ph.D., as President, Life Sciences
A globally accomplished executive, Dr. Mishra brings deep scientific and commercial experience, holding senior roles at Thermo Fisher Scientific, Gilead, and Pfizer. In his most recent role as General Manager of Real World Data at Thermo Fisher, he oversaw critical high-growth initiatives, including the company's global COVID-19 response.
As President of Life Sciences, Dr. Mishra will spearhead Press Ganey's work to redefine how life sciences companies engage with patients and providers across the product lifecycle—from clinical development through commercial delivery. By harnessing the company's unmatched expertise in human experience, advanced analytics, and technology, Dr. Mishra will lead efforts to unlock new levels of customer insight, accelerate decision-making, and drive operational efficiency across the life sciences ecosystem.
'Avanish is a proven innovator with both the scientific depth and commercial expertise to scale products that solve complex challenges,' Ryan said. 'His appointment signals a transformational moment for our company and our partners in life sciences. With Avanish at the helm, we will accelerate the shift toward more personalized, insight-driven engagement strategies that put people—patients, providers, and caregivers—at the center of innovation.'
Throughout his 20+ year career, Dr. Mishra has championed business transformation across the U.S., Japan, and APAC markets. While at Pfizer, he scaled a joint venture from inception to over $400 million in revenue in just three years. He holds a Ph.D. in Pharmacy Administration and has authored numerous publications widely cited in the scientific community.
About Press Ganey:
P ress Ganey partners with healthcare providers and health plans to improve the experiences of their patients and workforce by marrying data with unparalleled technology and expertise. Our HX platform unites and enlivens disparate data, enabling clients to gather, analyze, visualize, and act on key insights to retain employees and ensure the care journey is accessible, safe, equitable, and patient-centered. We are the trusted partner to over 41,000 healthcare provider organizations globally and 85% of health plans in the United States. Press Ganey is a PG Forsta company.
About PG Forsta
PG Forsta is the leading provider of experience technology, data analytics, and insights that help companies better understand and serve their customers, employees, and stakeholders. PG Forsta powers the Human Experience (HX) Platform – a comprehensive experience and research technology platform that brings together CX (Customer Experience), Employee Experience (EX), Patient Experience (PX) and Market Research. It serves more than 43,000 clients globally across healthcare, financial services, hospitality, market research, professional services, retail, and technology.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
2 hours ago
- New York Post
Media still undercounting return-to-office phenomenon
The media continues to absurdly undercount, downplay or misunderstand the return-to-office phenomenon, although the surge should be obvious from the current leasing frenzy and from crowds on the street. For example, Crain's last week questioned whether the 345 Park Ave. murders would 'impact the city's already stagnant return-to-office rates.' The story based its 'stagnant' claim partly on the Partnership for New York City's supposed finding that only '57% of Manhattan office workers had returned on the average workday.' 3 The Midtown shooting happened at 345 Park Ave. AFP via Getty Images 3 An NYPD police officer stands at the shattered glass entrance to 345 Park Avenue after the shooting. John Angelillo/UPI/Shutterstock 3 NYC office capacity was never full — even during pre-COVID times. Tierney – That — like many similar off-base readings of data — made it sound as if Manhattan offices that were full before 2020 are now barely more than half full. What the Partnership actually said in March was that 57% of workers in offices at the time 'equates to 76% of respondents' pre-pandemic attendance.' In other words, pre-pandemic offices were not 100% occupied — they never were — but 75% occupied. That's because 57 is 76% of 75. The 19% difference between 76% and 57% is much less than an alleged 43% gap between 100% and 57%. And with so many CEO's calling their staffs back, the 19% gap can only continue to shrink further.
The Hill
2 hours ago
- The Hill
Kennedy targets vaccination injury program
Health secretary Robert F. Kennedy Jr. is targeting a little-known but crucial program that underpins all childhood vaccinations. Kennedy took to social media and the show of conservative activist Charlie Kirk this week to rail against the Vaccine Injury Compensation Program and pledge significant changes. 'The VICP is broken, and I intend to fix it,' he wrote on social platform X. 'I will not allow the VICP to continue to ignore its mandate and fail its mission of quickly and fairly compensating vaccine-injured individuals.' Attorneys and other experts say Kennedy is right that the program, which was created in 1986 in order to give quick payouts to families who can prove a child was injured from a vaccine, is badly in need of modernization. 'There's a lot of low hanging fruit that [Kennedy] can act on that would immediately alter the course of the vaccine program for the better,' said David Carney, a vaccine injury attorney in Philadelphia and president of the Vaccine Injured Petitioners Bar Association. Cases could be settled quicker, rather than going through a trial, Carney said. Kennedy could also press Congress to act on legislation that would increase the court staff, increase the pain and suffering caps, and add COVID-19 vaccines to the list of shots eligible for the program. It has too few staff available to handle a massive caseload, leaving patients waiting for years just to have their cases heard. It covers almost three times as many vaccines as when it was first created, but the number of 'special masters' who hear cases has stayed the same. Attorneys who argue vaccine injuries said the government has been more favorable to vaccines than petitioners in recent years, fighting against claims that would have previously been easily settled. 'It's not the fast, informal, petitioner-friendly program that Congress designed. It is very adversarial and litigious. That's absolutely, 100% true,' said Renée Gentry, director of the Vaccine Injury Litigation Clinic at George Washington University Law School. But there's fear the changes Kennedy wants will undermine the program, or tear it down entirely, risking driving drugmakers from the market and threatening access to childhood shots. Kennedy has long targeted the VICP, and his X post echoed many of his previous arguments. He did not elaborate on what changes he is making but said he is working with Attorney General Pam Bondi. He has previously said he wants to expand the program, making it easier for claimants to qualify for awards based on adverse events he claims are associated with vaccines but are not currently part of the program. People can prove injuries two ways, said Dorit Reiss, a vaccine law expert and law professor at UC San Francisco. Either you fit into the table of injuries, and then there's a presumption that the vaccine caused the harm, or you have to show causation for an injury outside the list. Kennedy has the power to add new injuries to the eligible list, like autism, which he has repeatedly linked to vaccines. In an interview with Tucker Carlson earlier in July, Kennedy also suggested vaccines are linked to numerous chronic ailments like diabetes and narcolepsy. 'We have now this epidemic of immune dysregulation in our country, and there's no way to rule out vaccines as one of the key culprits,' Kennedy said. In order to add an injury to the list, Kennedy would have to go through the federal government's cumbersome notice-and-comment rulemaking process. Experts said it's usually a time consuming and expensive undertaking, and often the scientific reviews don't show enough evidence to prove if the vaccine caused harm or not. Kennedy could also unofficially start settling cases for more injuries without adding them to the list. Yet either change could risk bankrupting the program. Families are paid through a trust fund that's funded by an excise tax on vaccine makers, so there's a finite pot of money available. The program's fund covers lawyers' fees and the costs, even for losing cases. In exchange for the tax, vaccine makers have a limited liability shield. Petitioners file claims against the federal government, not the manufacturers, and families can get compensation without having to prove that drugmakers were negligent. Kennedy has suggested he wants to change that. 'The VICP has devolved into a morass of inefficiency, favoritism, and outright corruption as government lawyers and the Special Masters who serve as Vaccine Court judges prioritize the solvency of the HHS Trust Fund, over their duty to compensate victims,' Kennedy wrote. An HHS spokesman declined to say what, if any changes Kennedy is considering, saying the secretary's comments speak for itself. A popular anti-vaccine talking point is the desire to eliminate the vaccine makers' limited liability shield. But that's only something Congress can do. Kennedy does have the power to drop vaccines from the program. Right now, it covers 16 routinely recommended immunizations for children or pregnant women. But if a shot is no longer routinely recommended, it can be removed. In early June, Kennedy abruptly fired all members of the outside advisory group responsible for making vaccine recommendations. He appointed a new group of hand-picked replacements. If that group no longer recommends the HPV vaccine, for instance, Kennedy can revise the injury table to remove it. 'If he takes it away, then those people have no right to be in this program, and they're going to have to be stuck with civil litigation,' said Gentry, which is much more difficult and expensive.
The Hill
3 hours ago
- The Hill
What still causes the plague in the US?
(NEXSTAR) — Northern Arizona recently recorded its first pneumonic plague-related death since 2007. Early last year, Oregon saw its first case of the bubonic plague since 2015. Person-to-person spread of the plague hasn't been seen in more than 100 years in the U.S., but cases occasionally pop up. So what causes them? The plague cases reported in the U.S. today are not exactly the same as those seen in medieval Europe. Between 1347 and 1352 alone, it's estimated that the plague caused the deaths of at least 25 million Europeans. Rats aboard a ship from the Crimea and Asia that docked in Sicily are blamed for bringing the bubonic plague into Europe. Once fleas ran out of host rodents in Europe – those that lacked resistance to the plague also died – they sought out humans. Fungus labeled 'urgent threat' by CDC is spreading rapidly, hospital study finds Eventually, those who were sick or at risk of carrying the plague were isolated and put into quarantine, much like guidance issued during the COVID pandemic. A vaccine in the late 19th century, improved sanitation, better health practices and modern antibiotics have been credited with helping to stop the spread of the plague when it pops up. The U.S. now sees about seven cases annually, on average, according to estimates from the Centers for Disease Control and Prevention. The World Health Organization says most human cases over the last three decades have been in Africa. When cases do occur in the U.S., they're primarily in the West, with most reported in New Mexico and Arizona. Cases have also appeared within the region of southern Oregon, far western Nevada, and California. U.S. cases are, most often, bubonic. There are three main forms of the plague: bubonic (the most common during Europe's Black Death), septicemic, and pneumonic. Generally speaking, plague is brought on by the Yersinia pestis bacterium, with humans and mammals being affected. 'Quiet cracking' is the newest term for a workplace problem — and it's 'pretty pervasive,' expert says The three types of plague present with different symptoms and are caused by different things. Bubonic plague is caused by the bites of fleas that are mostly found on rodents. Symptoms of bubonic plague, the Cleveland Clinic explains, include a sudden high fever; chills; headaches; pain in the abdomen, arms, and legs; and large, swollen lymph nodes that can leak pus. While the bacteria will multiply in the lymph node where it entered the body, it's capable of spreading to other parts of the body if not treated with antibiotics. Septicemic plague has similar symptoms to bubonic plague, including fever, chills, extreme weakness, pain in the abdomen, shock, and the possibility of bleeding into the skin and other organs, the CDC explains. This form of plague can develop from untreated bubonic plague as well as from the handling of infected animals. Should a person with bubonic or septicemic plague go without treatment, and the bacteria reach their lungs, they can develop pneumonic plague. A person can also get pneumonic plague from breathing in 'droplets coughed out by another person or animal with pneumonic plague,' according to the CDC. Like other forms of plague, a person infected with pneumonic plague may develop a fever, headache, weakness, and pneumonia, with the latter developing 'rapidly.' While bubonic and septicemic plague may take a few days to set in, the incubation period for pneumonic plague may be just over a day, the CDC reports. It's the only form that can be spread person-to-person, and it is considered the most serious form of the disease. Between 2020 and 2023, the CDC reported 15 human plague cases were reported. Of those, three died. As the Cleveland Clinic explains, plague has to be treated with antibiotics as quickly as possible — taking antibiotics within 24 hours of symptoms gives you 'the best chance of getting better.' You could begin feeling better within a week or two, as long as you receive treatment, according to health experts. Regardless of the type of plague, about 90% survive with quick treatment. Untreated, 'plague is nearly always fatal,' the Cleveland Clinic said. Health officials have not said how the Arizona resident who died earlier this year of the pneumonic plague became infected. Oregon's case of bubonic plague last year was believed to be brought on by a pet cat. In recent years, Colorado has reported a cat testing positive for septicemic plague and a cat, two prairie dog colonies, and a squirrel testing positive for bubonic plague. Infected fleas are largely to blame for plague cases that occur in the U.S. today, but the handling of infected animals – like cats, rabbits, rats, mice, and squirrels, according to New York's Department of Health – has also been known to lead to the plague. To avoid getting the plague, it's recommended that you take steps to avoid flea bites. That includes wearing bug spray with DEET and clearing up spaces outside where the wild animals fleas love may live. It's also important to speak with your veterinarian about preventing fleas on your pets. Your pets should also not be allowed to roam outdoors freely if you live in an area prone to the plague.
